Beauty clinic operator Beauty Farm Medical and Health Industry Inc. (2373.HK) announced on Monday it expects to report its revenue for the first half of 2026 totaled 1.88 billion yuan ($277 million) or more, up 28% or higher. Its net profit is expected to total at least 235 million yuan, up at least 37%.
The company attributed the profit growth mainly to its dual-engine strategy of “internal growth + external acquisitions.” Beauty Farm acquired beauty service brand Siyanli last year, and has consolidated the company’s results into its own financial statements since January. The acquisition further expanded Beauty Farm’s presence in premium commercial districts across core cities and contributed additional revenue and profit.
During the period, Beauty Farm’s same-store revenue at directly operated stores continued to increase, while its beauty, wellness and consumer healthcare businesses all grew. Its CellCare unit launched anti-aging solutions that drove growth in both business volume and value for aesthetic medical services. Platform-based efficiencies and economies of scale also helped improve the company’s organic profit margin.
Beauty Farm shares opened higher on Monday and traded at HK$18.6 by the midday break, up 9.41%. The stock is down about 31.6% year to date.
By Lee Shih Ta
To subscribe to Bamboo Works weekly free newsletter, click here
